Mortality News and Research

RSS

Discovery of diverse sarbecovirus broadly neutralizing antibodies from SARS-CoV-2 “infected-vaccinated” humans

Scientists were inspired by the robust serum nAb responses in people who recovered from natural SARS-CoV-2 infection and were later vaccinated using mRNA vaccine. They isolated and characterized bnAbs from two COVID-19 convalescent donors who were recently vaccinated. These isolated bnAbs were found to be highly potent against sarbecoviruses. This research is available on the bioRxiv* preprint server.

13 Sep 2021

New online tool to predict mortality risk for patients with acute-on-chronic liver failure

For patients with chronic liver disease, the onset of acute-on-chronic liver failure (ACLF) instantly alters the transplant question from 'if' to 'when'. 60 to 70% of patients with ACLF die within 3 months due to poor liver function and multiple organ failure.

13 Sep 2021

Acid pH enhances SARS-CoV-2 infection by up-regulating ACE2 receptor

A new study published in the journal Frontiers of Medicine indicated that Barrett's esophagus (BE) and gastroesophageal reflux disease (GERD) may represent novel comorbidities associated with SARS-CoV-2 disease. A previous study had estimated that in the United States, 5.6% of adults have BE, a disease where esophageal squamous mucosa gets damaged by GERD.

12 Sep 2021

COVID-19 vaccines effective at preventing hospitalizations caused by the Delta variant

COVID-19 vaccines are effective at preventing hospitalizations and emergency department visits caused by the Delta variant, according to data from a national study.

12 Sep 2021

Electroconvulsive therapy reduces deaths by suicide among depressed elders

Electroconvulsive therapy reduces deaths by suicide among older adults with depression in the months immediately following hospitalization, researchers report in the 10 September issue of the American Journal of Psychiatry.

12 Sep 2021

Demographic analysis of patients affected by COVID-19 in the USA

A collaborative effort aimed to determine a possible demographic explanation of COVID-19 mortality on the basis of age, sex, and ethnicity.

12 Sep 2021

Study finds significant variability in treatment access for patients with malignant pleural mesothelioma

A study of 2,804 patients with stage I to stage III malignant pleural mesothelioma (MPM) found significant variability in access to care and a positive association between multimodality treatment, income levels, and survival outcomes.

12 Sep 2021

Microscopy paired with AI leads to a fast, accurate, and cost-effective COVID-19 test

Beckman researchers paired microscopy with artificial intelligence to develop a COVID-19 test that's fast, accurate, and cost-effective. All we need to do is say "ahh."

12 Sep 2021

Meat dependence reduced population density of hunter-gatherer groups

A new study by the ICTA-UAB establishes that the population density of hunter-gatherer groups was reduced where they depended heavily on meat to survive.

12 Sep 2021

FB-EVAR is safe and effective for treatment of aortic aneurysms, study shows

A recent study revealed that endovascular repair of complex aortic aneurysms using fenestrated and branched endografts provides a safe and effective alternative to open surgical repair, with the lowest ever reported mortality rate in this patient population, according to researchers at The University of Texas Health Science Center at Houston and Memorial Hermann Heart and Vascular Institute Aortic Center.

10 Sep 2021

Study: Canadians have the highest risk of respiratory mortality from wildfire pollution

An international study has found Canadians have the highest relative risk of respiratory mortality resulting from wildfire pollution, with Regina and Saskatoon among the worst hit.

10 Sep 2021

Study documents the added value of hospitals employing inpatient nurse practitioners

According to a new study published today in Medical Care, hospitals that employ more inpatient nurse practitioners (NPs) have lower surgical mortality, higher patient satisfaction, and lower costs of care.

10 Sep 2021

Virus-like nanoparticle vaccine effective against SARS-CoV-2 in animal model

A COVID-19 vaccine, created from a virus-like nanoparticle that displays SARS-CoV-2 spike protein RBDs, effectively protects animal model from infection.

10 Sep 2021

Study finds increasing disparities in opioid overdose deaths for Black people

Non-Hispanic Black individuals in four U.S. states experienced a 38% increase in the rate of opioid overdose deaths from 2018 to 2019, while the rates for other race and ethnicity groups held steady or decreased, according to a new study by the National Institutes of Health published in the American Journal of Public Health.

9 Sep 2021

Report highlights the health effects of COVID-19 on Australians during 2020 and early 2021

A new report into the health effects of COVID-19 on Australians during 2020 and early 2021 includes analyses of the years of healthy life lost, international comparisons and impacts on population groups, mental health and the health system.

9 Sep 2021

Early impact of COVID-19 vaccines in Stockholm, Sweden

A study shows that the early programmatic effects of vaccinating high-risk individuals can reduce infection and mortality by SARS-CoV-2.

9 Sep 2021

Study: Nearly one in five patients with malignant pleural mesothelioma contracted COVID-19

Nearly one in five patients with malignant pleural mesothelioma (MPM) at a Barcelona hospital contracted COVID-19 during the pandemic.

8 Sep 2021

The role of nanobodies in capturing and containing SARS-CoV-2

Scientists have repurposed the Nb Ty1 for the detection and neutralization of SARS-CoV-2.

8 Sep 2021

Study reveals better outcomes for patients treated on a mobile stroke unit

Ischemic stroke patients treated on a mobile stroke unit received anti-clot medication faster and ended up with less disability at 90 days, according to a study published today in the New England Journal of Medicine led by researchers at The University of Texas Health Science Center at Houston and Memorial Hermann-Texas Medical Center.

8 Sep 2021

Genetically predicted COVID-19 linked to blood clots, thrombophlebitis and circulatory diseases

Research led by Queen Mary University of London associates genetically determined COVID-19 susceptibility with increased blood clot events in leg and lungs, thrombophlebitis and circulatory diseases.

8 Sep 2021

Mortality News and Research

Discovery of diverse sarbecovirus broadly neutralizing antibodies from SARS-CoV-2 “infected-vaccinated” humans

New online tool to predict mortality risk for patients with acute-on-chronic liver failure

Acid pH enhances SARS-CoV-2 infection by up-regulating ACE2 receptor

COVID-19 vaccines effective at preventing hospitalizations caused by the Delta variant

Electroconvulsive therapy reduces deaths by suicide among depressed elders

Demographic analysis of patients affected by COVID-19 in the USA

Study finds significant variability in treatment access for patients with malignant pleural mesothelioma

Microscopy paired with AI leads to a fast, accurate, and cost-effective COVID-19 test

Meat dependence reduced population density of hunter-gatherer groups

FB-EVAR is safe and effective for treatment of aortic aneurysms, study shows

Study: Canadians have the highest risk of respiratory mortality from wildfire pollution

Study documents the added value of hospitals employing inpatient nurse practitioners

Virus-like nanoparticle vaccine effective against SARS-CoV-2 in animal model

Study finds increasing disparities in opioid overdose deaths for Black people

Report highlights the health effects of COVID-19 on Australians during 2020 and early 2021

Early impact of COVID-19 vaccines in Stockholm, Sweden

Study: Nearly one in five patients with malignant pleural mesothelioma contracted COVID-19

The role of nanobodies in capturing and containing SARS-CoV-2

Study reveals better outcomes for patients treated on a mobile stroke unit

Genetically predicted COVID-19 linked to blood clots, thrombophlebitis and circulatory diseases

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News